Early Detection of Adverse Events with Daily Remote Monitoring versus Quarterly Standard Follow-Up Program in Patients with CRT-D

被引:16
作者
De Ruvo, Ermenegildo [1 ]
Gargaro, Alessio [2 ]
Sciarra, Luigi [1 ]
De Luca, Lucia [1 ]
Zuccaro, Lorenzo Maria [1 ]
Stirpe, Federica [1 ]
Rebecchi, Marco [1 ]
Sette, Antonella [1 ]
Lioy, Ernesto [1 ]
Calo, Leonardo [1 ]
机构
[1] UOC Cardiol, Policlin Casilino, ASL Roma B, Rome, Italy
[2] Biotron Italia Srl, Vimodrone, MI, Italy
来源
PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY | 2011年 / 34卷 / 02期
关键词
CRT; ICD; remote monitoring; telemedicine; heart failure; RESYNCHRONIZATION THERAPY SYSTEMS; HEART-FAILURE; CARDIOVERTER-DEFIBRILLATORS; CLINICAL MANAGEMENT; CONSENSUS STATEMENT; ATRIAL-FIBRILLATION; IMPLANTED DEVICES; ICD; WIRELESS; ACCEPTANCE;
D O I
10.1111/j.1540-8159.2010.02932.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Methods and Results: We retrospectively analyzed RM database and hospital files of 99 CRT-D consecutive patients who were visited in the out-patient clinic every 3-4 months; thirty-three patients were in addition controlled remotely with RM (RM group). Kaplan-Meier curves of clinical or device-related AE-free rates were obtained. During a median follow-up of 7 months, clinical AEs were: ventricular and atrial arrhythmias in 14 and 11 patients, low CRT pacing in nine, heart failure, strokes, or death in 15. Device-related AEs were: insufficient pacing/sensing performances in nine patients, lead dislodgement in five. As comparing the RM group with the remaining patients, Kaplan-Meier curves of clinical AEs diverged to significantly different rates: 23.8% (confidence interval [CI] 0.1%-47.5%) in the RM group and 48.7% (21.6-75.7%) in the remaining patients (P = 0.00002), with a hazard ratio of 0.14 (CI 0.06-0.37). Nondivergent Kaplan-Meier curves were obtained for device-related AE-free rates. Conclusion: CRT-D patients followed with quarterly in-office visits without a daily RM system had an 86% higher risk of delayed detection of clinical AEs, during a median follow-up of 7 months. (PACE 2011; 34:208-216).
引用
收藏
页码:208 / 216
页数:9
相关论文
共 29 条
[1]   Continuous autonomic assessment in patients with symptomatic heart failure - Prognostic value of heart rate variability measured by an implanted cardiac resynchronization device [J].
Adamson, PB ;
Smith, AL ;
Abraham, WT ;
Kleckner, KJ ;
Stadler, RW ;
Shih, A ;
Rhodes, MM .
CIRCULATION, 2004, 110 (16) :2389-2394
[2]   Remote Monitoring of Implantable Cardioverter Defibrillators versus Quarterly Device Interrogations in Clinic: Results from a Randomized Pilot Clinical Trial [J].
Al-Khatib, Sana M. ;
Piccini, Jonathan P. ;
Knight, David ;
Stewart, Margaret ;
Clapp-Channing, Nancy ;
Sanders, Gillian D. .
JOURNAL OF CARDIOVASCULAR ELECTROPHYSIOLOGY, 2010, 21 (05) :545-550
[3]  
Boriani G, 2006, AM HEART J, V152, P527, DOI 10.1016/j.ahj.2006.03.003
[4]   Clinical Benefits of Remote Versus Transtelephonic Monitoring of Implanted Pacemakers [J].
Crossley, George H. ;
Chen, Jane ;
Choucair, Wassim ;
Cohen, Todd J. ;
Gohn, Douglas C. ;
Ben Johnson, W. ;
Kennedy, Eleanor E. ;
Mongeon, Luc R. ;
Serwer, Gerald A. ;
Qiao, Hongyan ;
Wilkoff, Bruce L. .
JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2009, 54 (22) :2012-2019
[5]   Atrial Fibrillation Therapy in Patients with a CRT Defibrillator with Wireless Telemetry [J].
Crossley, George H. ;
Aonuma, Kazutaka ;
Haffajee, Charles ;
Shoda, Morio ;
Meijer, Albert ;
Bauer, Alexander ;
Boriani, Giuseppe ;
Svendsen, Jesper ;
Thomas, Shelley ;
Wiggenhorn, Christopher ;
Unterberg-Buchwald, Christina .
PACE-PACING AND CLINICAL ELECTROPHYSIOLOGY, 2009, 32 (01) :13-23
[6]  
Gillis AM, 2003, CAN J CARDIOL, V19, P21
[7]   Implantation of cardiac resynchronization therapy systems in the CARE-HF trial:: procedural success rate and safety [J].
Gras, D. ;
Boecker, D. ;
Lunati, M. ;
Wellens, H. J. J. ;
Calvert, M. ;
Freemantle, N. ;
Gervais, R. ;
Kappenberger, L. ;
Tavazzi, L. ;
Erdmann, E. ;
Cleland, J. G. F. ;
Daubert, J.-C. .
EUROPACE, 2007, 9 (07) :516-522
[8]  
Higgins SL, 1999, AM J CARDIOL, V83, p79D
[9]   Effect of moderate or intensive disease management program on outcome in patients with heart failure [J].
Jaarsma, Tiny ;
van der Wal, Martje H. L. ;
Lesman-Leegte, Ivonne ;
Luttik, Marie-Louise ;
Hogenhuis, Jochem ;
Veeger, Nic J. ;
Sanderman, Robbert ;
Hoes, Arno W. ;
van Gilst, Wiek H. ;
Lok, Dirk J. A. ;
Dunselman, Peter H. J. M. ;
Tijssen, Jan G. P. ;
Hillege, Hans L. ;
Van Veldhuisen, Dirk J. .
ARCHIVES OF INTERNAL MEDICINE, 2008, 168 (03) :316-324
[10]  
Lazarus A, 2007, PACE, V30, pS2